# Tariq Ahmad

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/tariq-ahmad/

## Facts

| Field | Value |
| --- | --- |
| Citations | 31,518 |
| Field | Inflammatory Bowel Disease |
| h-index | 64 |
| i10-index | 127 |
| OpenAlex ID | https://openalex.org/A5069067500 |
| ORCID iD | https://orcid.org/0000-0002-6058-5528 |
| Works | 331 |

## Researcher papers

- [Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease](https://scholariq.org/papers/host-microbe-interactions-have-shaped-the-genetic-architecture-of-inflammatory/)
- [Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology](https://scholariq.org/papers/toward-an-integrated-clinical-molecular-and-serological-classification-of/)
- [Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease](https://scholariq.org/papers/genome-wide-association-defines-more-than-30-distinct-susceptibility-loci-for/)
- [Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci](https://scholariq.org/papers/genome-wide-meta-analysis-increases-to-71-the-number-of-confirmed-crohn-s/)
- [Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility](https://scholariq.org/papers/sequence-variants-in-the-autophagy-gene-irgm-and-multiple-other-replicating-loci/)
- [Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study](https://scholariq.org/papers/predictors-of-anti-tnf-treatment-failure-in-anti-tnf-naive-patients-with-active/)
- [HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn’s Disease](https://scholariq.org/papers/hla-dqa1-05-carriage-associated-with-development-of-anti-drug-antibodies-to/)
- [A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial](https://scholariq.org/papers/a-biomarker-stratified-comparison-of-top-down-versus-accelerated-step-up/)
- [COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study](https://scholariq.org/papers/covid-19-vaccine-induced-antibody-responses-in-immunosuppressed-patients-with/)
- [Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study](https://scholariq.org/papers/mechanisms-and-management-of-loss-of-response-to-anti-tnf-therapy-for-patients/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Immunodeficiency and Autoimmune Disorders](https://scholariq.org/topics/immunodeficiency-and-autoimmune-disorders/)
- [Biosimilars and Bioanalytical Methods](https://scholariq.org/topics/biosimilars-and-bioanalytical-methods/)
- [Helicobacter pylori-related gastroenterology studies](https://scholariq.org/topics/helicobacter-pylori-related-gastroenterology-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.